Subcutaneous Interferon-??-1a
| Autor: | Antona J. Wagstaff, Kate McKeage |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Pathology
medicine.medical_specialty business.industry Immunogenicity Multiple sclerosis Interferon beta-1a Neopterin Pharmacology medicine.disease Psychiatry and Mental health Interferon β 1a chemistry.chemical_compound Pharmacokinetics Tolerability chemistry medicine Pharmacology (medical) Neurology (clinical) Cladribine business medicine.drug |
| Zdroj: | CNS Drugs. 21:871-876 |
| ISSN: | 1172-7047 |
| DOI: | 10.2165/00023210-200721100-00006 |
| Popis: | ▲ The new formulation of subcutaneous interferon-β-1a was developed without serum-derived components with the aim of improving immunogenicity and injection tolerability in patients with relapsing forms of multiple sclerosis (MS). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink